title: Clinical significance of fibroblast growth factor (FGF) expression in colorectal cancer.
abstract: In this study, we serologically and pathologically examined the clinical significance of fibroblast growth factor (FGF) expression in patients with colorectal cancer. Serum basic FGF (bFGF) levels in 92 surgical colorectal cancer patients and 31 controls were measured, and the relationship between those levels and clinicopathological factors were examined. Immunohistochemical study was also conducted on specimens from 51 cancer patients, and the association between bFGF staining and serum levels were investigated. An examination of clinicopathological factors revealed significant differences in bFGF levels between stage 0-IIIb and stage IV cancers (P = 0.013). Lymphatic invasion was one factor that differed significantly. Patients with a tumor 30 mm or smaller had a bFGF level of 7.65 ± 1.11 pg/ml while patients with a tumor 31 mm or larger had a bFGF level of 8.53 ± 3.22 pg/ml; significant differences in these bFGF levels were noted (P < 0.05). Patients with a tumor that had no lymphatic invasion (ly0) had a bFGF level of 7.25 ± 0.66 pg/ml, those with a tumor that had minimal lymphatic invasion (ly1) had a bFGF level of 7.99 ± 1.68 pg/ml, and those with a tumor that had moderate lymphatic invasion (ly2) had a bFGF level of 9.17 ± 4.23 pg/ml. bFGF levels differed significantly for tumors with no/minimal lymphatic invasion (ly0-ly1) and those with moderate lymphatic invasion (ly2) (P < 0.0001). Serological examination of bFGF levels during the proliferation of colorectal cancer revealed that moderate lymphatic invasion can be readily distinguished.
authors.affiliation: 1 Department of Surgery II, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Norie
authors.initials: N
authors.lastname: Jibiki
authors.forename: Noboru
authors.initials: N
authors.lastname: Saito
authors.forename: Shingo
authors.initials: S
authors.lastname: Kameoka
authors.forename: Makio
authors.initials: M
authors.lastname: Kobayashi
mesh_terms: D015179:Colorectal Neoplasms / Q000737:chemistry* / Q000473:pathology*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000097:blood; D005346:Fibroblast Growth Factors / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D008208:Lymphatic System / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness
chemical_list: D016222:Fibroblast Growth Factor 2; D005346:Fibroblast Growth Factors